ALEXANDRIA, Va., Feb. 12 -- United States Patent no. 12,220,411, issued on Feb. 11, was assigned to THE EYE HOSPITAL OF WENZHOU MEDICAL UNIVERSITY (Wenzhou, China).

"Application of PTGDS inhibitor in preparation of drug for treating cataracts" was invented by Jin Li (Wenzhou, China), Jiasheng Liu (Wenzhou, China), Yitong Xu (Wenzhou, China), Mengchao Zhu (Wenzhou, China) and Haisen Sun (Wenzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Application of a PTGDS inhibitor in preparation of a drug for treating cataracts is provided. As an effective and selective PTGDS inhibitor, AT-56 competitively inhibits production of PGD2 by occupying a catalytic site of PTGDS. The PTGDS catalyzes synthesis of the...